• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖儿童非酒精性脂肪肝病的生活方式干预:2年随访研究。

Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.

作者信息

Reinehr T, Schmidt C, Toschke A M, Andler W

机构信息

Vestische Hospital for Children and Adolescents, University of Witten-Herdecke, Datteln, Germany.

出版信息

Arch Dis Child. 2009 Jun;94(6):437-42. doi: 10.1136/adc.2008.143594. Epub 2009 Feb 17.

DOI:10.1136/adc.2008.143594
PMID:19224892
Abstract

OBJECTIVE

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in obese youth. Lifestyle intervention was demonstrated to improve NAFLD but follow-up studies after end of intervention are lacking. Furthermore the necessary degree of overweight reduction for improvement of NAFLD remains unknown.

METHODS

We examined standard deviation score of body mass index (SDS-BMI) and transaminases in 152 obese children with NAFLD diagnosed by ultrasound at baseline, at the end of a 1-year intervention and 2 years after baseline. Within-subject changes of these parameters were compared by participation in the intervention based on physical activity, nutrition education and behaviour therapy.

RESULTS

In contrast to 43 children without lifestyle intervention, participation in lifestyle intervention (n = 109) was associated with a significant decrease of transaminases and overweight 1 and 2 years after baseline (1 year: alanine transaminase (ALT) -10 U/l (-14 to -6); aspartate transaminase (AST) -5 U/l (-7 to -3); SDS-BMI -0.23 (-0.30 to -0.16); 2 years: ALT -9 U/l (-12 to -6); AST -6 U/l (-7 to -4); SDS-BMI -0.30 (-0.37 to -0.22); data as mean changes and 95% confidence interval compared to baseline). Any degree of overweight reduction was associated with a significant decrease of NAFLD prevalence. The greatest decrease of NAFLD prevalence (1 year: -89% (95% CI -72% to -100%); 2 years: -94% (95% CI -83% to -100%)) was observed in children with the greatest overweight reduction (SDS-BMI decrease >0.5).

CONCLUSIONS

Multidisciplinary lifestyle intervention is effective to improve NAFLD even in the 1-year follow-up after the end of intervention. A minimal reduction of overweight led to an improvement of NAFLD.

TRIAL REGISTRATION NUMBER

NCT00435734.

摘要

目的

非酒精性脂肪性肝病(NAFLD)是肥胖青少年肝病最常见的病因。生活方式干预已被证明可改善NAFLD,但干预结束后的随访研究尚缺。此外,改善NAFLD所需的体重减轻程度仍不清楚。

方法

我们检测了152名经超声诊断为NAFLD的肥胖儿童在基线、1年干预结束时及基线后2年的体重指数标准差评分(SDS-BMI)和转氨酶水平。通过参与基于体育活动、营养教育和行为疗法的干预,比较这些参数的个体内变化。

结果

与43名未进行生活方式干预的儿童相比,参与生活方式干预(n = 109)的儿童在基线后1年和2年时转氨酶水平和超重情况显著下降(1年:丙氨酸转氨酶(ALT)-10 U/L(-14至-6);天冬氨酸转氨酶(AST)-5 U/L(-7至-3);SDS-BMI -0.23(-0.30至-0.16);2年:ALT -9 U/L(-12至-6);AST -6 U/L(-7至-4);SDS-BMI -0.30(-0.37至-0.22);数据为与基线相比的平均变化及95%置信区间)。任何程度的体重减轻都与NAFLD患病率的显著降低相关。在体重减轻最多(SDS-BMI下降>0.5)的儿童中,观察到NAFLD患病率下降幅度最大(1年:-89%(95%CI -72%至-100%);2年:-94%(95%CI -83%至-100%))。

结论

多学科生活方式干预即使在干预结束后的1年随访中对改善NAFLD也是有效的。体重的最小程度减轻也能改善NAFLD。

试验注册号

NCT00435734。

相似文献

1
Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.肥胖儿童非酒精性脂肪肝病的生活方式干预:2年随访研究。
Arch Dis Child. 2009 Jun;94(6):437-42. doi: 10.1136/adc.2008.143594. Epub 2009 Feb 17.
2
Association between leptin and transaminases: 1-year follow-up study in 180 overweight children.瘦素与转氨酶之间的关联:对180名超重儿童的1年随访研究。
Metabolism. 2009 Apr;58(4):497-503. doi: 10.1016/j.metabol.2008.11.007.
3
Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.成纤维细胞生长因子 21(FGF-21)及其与儿童肥胖、代谢综合征和非酒精性脂肪性肝病的关系:一项纵向分析。
J Clin Endocrinol Metab. 2012 Jun;97(6):2143-50. doi: 10.1210/jc.2012-1221. Epub 2012 Mar 21.
4
[Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].[非酒精性脂肪性肝病及其与肥胖儿童和青少年临床及生化变量的关联:为期一年的生活方式干预效果]
Endocrinol Nutr. 2012 Jun-Jul;59(6):346-53. doi: 10.1016/j.endonu.2012.05.002. Epub 2012 Jun 19.
5
Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.内脏脂肪组织和炎症与超重和肥胖患者队列中肝酶升高相关。
Int J Obes (Lond). 2010 May;34(5):899-907. doi: 10.1038/ijo.2010.4. Epub 2010 Feb 9.
6
Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.非酒精性脂肪肝的生活方式干预:其疗效及改善相关因素的前瞻性队列研究。
Arch Dis Child. 2011 Jul;96(7):669-74. doi: 10.1136/adc.2010.199760. Epub 2011 Apr 25.
7
Leptin concentrations are a predictor of overweight reduction in a lifestyle intervention.在生活方式干预中,瘦素浓度是体重减轻的一个预测指标。
Int J Pediatr Obes. 2009;4(4):215-23. doi: 10.3109/17477160902952464.
8
Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease.非酒精性脂肪肝患儿生活方式干预 1 年后的动脉功能和结构变化。
Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):1010-6. doi: 10.1016/j.numecd.2012.08.003. Epub 2012 Sep 24.
9
Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.二甲双胍用于非酒精性脂肪性肝病儿童:一项开放标签、为期24个月的观察性试点研究。
Clin Ther. 2008 Jun;30(6):1168-76. doi: 10.1016/j.clinthera.2008.06.012.
10
Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic.英国一家肥胖症诊所中代谢综合征儿童的肝功能异常。
Arch Dis Child. 2011 Nov;96(11):1003-7. doi: 10.1136/adc.2010.190975. Epub 2010 Nov 19.

引用本文的文献

1
Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease.运动治疗小儿代谢功能障碍相关脂肪性肝病的系统评价
PLoS One. 2024 Dec 10;19(12):e0314542. doi: 10.1371/journal.pone.0314542. eCollection 2024.
2
Association between BMI Change, Transaminases, and Other Metabolic Parameters in Children with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患儿体重指数变化与转氨酶及其他代谢参数的关系。
J Obes. 2024 May 23;2024:6997280. doi: 10.1155/2024/6997280. eCollection 2024.
3
The effects of weight loss interventions on children and adolescents with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
减肥干预措施对非酒精性脂肪性肝病儿童及青少年的影响:一项系统评价与荟萃分析。
Obes Sci Pract. 2024 Apr 26;10(3):e758. doi: 10.1002/osp4.758. eCollection 2024 Jun.
4
Lipidome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys with Metabolic Dysfunction-Associated Steatotic Liver Disease.与饮食诱导的代谢功能障碍相关脂肪性肝病的青春期男孩肝脏脂肪减少相关的脂质组变化
Metabolites. 2024 Mar 28;14(4):191. doi: 10.3390/metabo14040191.
5
Validation of a screening panel for pediatric metabolic dysfunction-associated steatotic liver disease using metabolomics.基于代谢组学的儿童代谢功能相关脂肪性肝病筛查面板的验证。
Hepatol Commun. 2024 Feb 26;8(3). doi: 10.1097/HC9.0000000000000375. eCollection 2024 Mar 1.
6
Rare genetic forms of obesity in childhood and adolescence: A narrative review of the main treatment options with a focus on innovative pharmacological therapies.儿童和青少年罕见遗传性肥胖症:主要治疗选择的叙述性综述,重点关注创新的药理学疗法。
Eur J Pediatr. 2024 Apr;183(4):1499-1508. doi: 10.1007/s00431-024-05427-4. Epub 2024 Jan 16.
7
The Impact and Burden of Dietary Sugars on the Liver.饮食糖对肝脏的影响和负担。
Hepatol Commun. 2023 Nov 6;7(11). doi: 10.1097/HC9.0000000000000297. eCollection 2023 Nov 1.
8
SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.SPIOMET4HEALTH 研究方案:生活方式干预联合螺内酯、吡格列酮和二甲双胍固定剂量复方治疗青春期女孩和年轻女性多囊卵巢综合征的疗效、耐受性和安全性:一项多中心、随机、双盲、安慰剂对照、四臂、平行分组、二期临床试验
Trials. 2023 Sep 15;24(1):589. doi: 10.1186/s13063-023-07593-6.
9
Metabolome × Microbiome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys.与饮食诱导的青少年男性肝脏脂肪减少相关的代谢组学×微生物组变化
Metabolites. 2023 Mar 8;13(3):401. doi: 10.3390/metabo13030401.
10
Antisense oligonucleotide is a promising intervention for liver diseases.反义寡核苷酸是一种很有前景的肝脏疾病干预手段。
Front Pharmacol. 2022 Dec 9;13:1061842. doi: 10.3389/fphar.2022.1061842. eCollection 2022.